Table 3.
Prognostic role of lncRNAs in CAD (OS, overall survival).
LncRNA | Samples | Kaplan–Meier analysis | Univariate analysis | Multivariate analysis | References |
---|---|---|---|---|---|
CASC11 | Plasma samples from 82 CAD patients and 82 age- and gender-matched healthy individuals | Its low expression was associated with decreased overall survival in CAD patients | – | – | (19) |
ANRIL | 327 patients with CAD | – | Its expression was correlated with CAD patients survival | Its expression can be an independent predictor of CAD patients' survival | (20) |
LEF1-AS1 | Tissue specimens from 70 patients with coronary artery atherosclerosis and 30 healthy controls | High expression of LEF1-AS1 was associated with poor OS. | – | – | (28) |
ANRIL | Plasma samples from 125 CAD patients and 105 control individuals | High expression of ANRIL was associated with shorter OS in CAD patients. | – | – | (44) |